Essex Bio-Technology Limited (1061.HK) HKSE

5.08

-0.09(-1.74%)

Updated at September 29 04:08PM

Currency In HKD

Essex Bio-Technology Limited

Address

No. 88 Keji 6th Road

Zhuhai,

China

Phone

86 75 6391 1188

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1450

First IPO Date

June 27, 2001

Key Executives

NameTitlePayYear Born
Ms. Lai Man Yau A.C.A., C.P.A., M.B.A.Executive Director & Company Secretary737,3801964
Mr. Hian Leng NgiamExecutive Director & Deputy MD1.8M1985
Mr. Haizhou FangMD & Executive Director1.83M1966
Dr. Mia Je Ngiam B.Sc.Founder & Chairman3.23M1955
Dr. Qi XueGroup Chief Scientific Officer01962

Description

Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series, such as Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops; Tobramycin eye drops, Levofloxacin eye drops, and Sodium Hyaluronate eye drops, as well as Iodized Lecithin Capsules. It also provides Beifuji sprays and lyophilized powder, and Beifuxin gels for use in burn and scald wounds, acute wounds, surgical incisions, chronic wounds, skin grafting, and other applications. In addition, it offers ophthalmic and surgical products from third parties. Further, the company offers Carisolv dental caries removal gel; and Yi Xue An Granules. It has license agreements with Mitotech S.A. and Mitotech LLC. The company was founded in 1990 and is headquartered in Zhuhai, China.